After the concept of radiomics was first proposed in 2012
it has been developed rapidly in the field of computed tomography (CT)
magnetic resonance imaging (MRI) and ultrasound. Positron emission tomography (PET)/CT radiomics has been successfully applied and made great progresses in the diagnosis
staging
prognosis
therapy outcome prediction and radiogenomics of different kinds of tumors. These tumors included the head and neck tumors
thoracic tumors
abdominal and pelvic tumors and the other tumors. This article comprehensively reviewed the concept
routine work flow
clinical application
development trend and challenges of PET/CT radiomics.